Activity of Imipenem-Relebactam against Multidrug- and Extensively Drug-Resistant Burkholderia cepacia Complex and Burkholderia gladioli.

Anti-Bacterial Agents / pharmacology Azabicyclo Compounds / pharmacology Burkholderia Burkholderia cepacia complex / drug effects Burkholderia gladioli / drug effects Drug Resistance, Multiple, Bacterial Imipenem / pharmacology Microbial Sensitivity Tests beta-Lactamases
Burkholderia PenA antibiotic resistance avibactam carbapenemase ceftazidime imipenem relebactam β-lactam β-lactamase inhibitor β-lactamases

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
18 10 2021
Historique:
pubmed: 10 8 2021
medline: 3 11 2021
entrez: 9 8 2021
Statut: ppublish

Résumé

The Burkholderia cepacia complex (Bcc) and Burkholderia gladioli are opportunistic pathogens that most commonly infect persons with cystic fibrosis or compromised immune systems. Members of the

Identifiants

DOI: 10.1128/AAC.01332-21 PMID: 34370574 PMC: PMC8522746
pubmed: 34370574
doi: 10.1128/AAC.01332-21
pmc: PMC8522746
doi:

Substances chimiques

Anti-Bacterial Agents 0
Azabicyclo Compounds 0
Imipenem 71OTZ9ZE0A
beta-Lactamases EC 3.5.2.6
relebactam Y1MYA2UHFL

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0133221

Subventions

Organisme : BLRD VA
ID : I01 BX002872
Pays : United States
Organisme : U.S. Department of Veterans Affairs (VA)
ID : BX002872
Organisme : Cystic Fibrosis Foundation (CF Foundation)

Références

Transpl Infect Dis. 2018 Oct;20(5):e12955
pubmed: 29896802
Antimicrob Agents Chemother. 2018 Apr 26;62(5):
pubmed: 29530851
J Clin Microbiol. 2000 Sep;38(9):3165-73
pubmed: 10970351
ACS Infect Dis. 2017 Jul 14;3(7):502-511
pubmed: 28264560
J Antimicrob Chemother. 2010 Nov;65(11):2376-81
pubmed: 20801783
Antimicrob Agents Chemother. 2012 Aug;56(8):4428-38
pubmed: 22687511
Transpl Infect Dis. 2019 Apr;21(2):e13034
pubmed: 30548546
Expert Opin Pharmacother. 2019 Dec;20(17):2169-2184
pubmed: 31500471
Indian J Med Microbiol. 2011 Jan-Mar;29(1):4-12
pubmed: 21304187
Environ Microbiol. 2011 Jan;13(1):1-12
pubmed: 20880095
Antimicrob Agents Chemother. 2018 Mar 27;62(4):
pubmed: 29588357
J Clin Microbiol. 2019 Jul 26;57(8):
pubmed: 31167848
Bioorg Med Chem Lett. 2014 Feb 1;24(3):780-5
pubmed: 24433862
Clin Microbiol Rev. 2010 Jan;23(1):160-201
pubmed: 20065329
Diagn Microbiol Infect Dis. 2018 Nov;92(3):253-258
pubmed: 29983287
Antimicrob Agents Chemother. 2018 May 25;62(6):
pubmed: 29610205
Antimicrob Agents Chemother. 1988 Jun;32(6):838-43
pubmed: 3046483
J Biol Chem. 2013 Jun 28;288(26):19090-102
pubmed: 23658015
Pediatr Pulmonol. 2020 Feb;55(2):283-284
pubmed: 31682316
Antimicrob Agents Chemother. 2009 Mar;53(3):876-82
pubmed: 19075063
Infection. 2019 Apr;47(2):289-292
pubmed: 30565008
Antimicrob Agents Chemother. 2010 Feb;54(2):890-7
pubmed: 20008772
Antimicrob Agents Chemother. 2019 Dec 20;64(1):
pubmed: 31611364
J Biol Chem. 2013 Sep 27;288(39):27960-71
pubmed: 23913691
Antimicrob Agents Chemother. 1997 Nov;41(11):2399-405
pubmed: 9371340
Antimicrob Agents Chemother. 2014 Aug;58(8):4290-7
pubmed: 24820081
J Antimicrob Chemother. 2019 Feb 1;74(2):525-528
pubmed: 30312409
Core Evid. 2014 Jan 24;9:13-25
pubmed: 24493994
Appl Environ Microbiol. 2005 Jul;71(7):3917-27
pubmed: 16000805
Antimicrob Agents Chemother. 1994 Feb;38(2):407-8
pubmed: 7514860
Antimicrob Agents Chemother. 2018 Aug 27;62(9):
pubmed: 29914964
Infect Dis Clin North Am. 2016 Jun;30(2):441-464
pubmed: 27208767
Antimicrob Agents Chemother. 2010 Mar;54(3):969-76
pubmed: 19995920
Transpl Infect Dis. 2019 Jun;21(3):e13082
pubmed: 30892778
Antimicrob Agents Chemother. 2018 Sep 24;62(10):
pubmed: 30012762
Antimicrob Agents Chemother. 2020 Nov 17;64(12):
pubmed: 32928739
J Antimicrob Chemother. 2019 May 1;74(5):1425-1429
pubmed: 30649419

Auteurs

Scott A Becka (SA)

Research Service, VA Northeast Healthcare System, Cleveland, Ohio, USA.

Elise T Zeiser (ET)

Research Service, VA Northeast Healthcare System, Cleveland, Ohio, USA.

John J LiPuma (JJ)

Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan, USA.
ORCID: 0000-0003-4033-7794

Krisztina M Papp-Wallace (KM)

Research Service, VA Northeast Healthcare System, Cleveland, Ohio, USA.
Departments of Medicine and Biochemistry, Case Western Reserve University, Cleveland, Ohio, USA.
ORCID: 0000-0002-9976-7898

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male

Management of the infected total elbow arthroplasty.

Joaquin Sanchez-Sotelo
1.00
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents

Mathematical modeling of vancomycin release from Poly-L-Lactic Acid-Coated implants.

Papon Thamvasupong, Kwanchanok Viravaidya-Pasuwat
1.00
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Menthol as an effective inhibitor of quorum sensing and biofilm formation in Candida albicans and Candida glabrata by targeting the transcriptional repressor TUP1.

Pouria Khodavandi, Maryam Miri Soogh, Fahimeh Alizadeh et al.
1.00
Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Activity of Imipenem-Relebactam against...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques, cycle ponté › Composés hétérocycliques bicycliques › Composés azabicycliques › Activity of Imipenem-Relebactam against...
questionsmedicales.fr › Bactéries › Proteobacteria › Betaproteobacteria › Burkholderiales › Burkholderiaceae › Burkholderia › Activity of Imipenem-Relebactam against...
questionsmedicales.fr › Bactéries › Proteobacteria › Betaproteobacteria › Burkholderiales › Burkholderiaceae › Burkholderia › Burkholderia cepacia complex › Activity of Imipenem-Relebactam against...
questionsmedicales.fr › Bactéries › Proteobacteria › Betaproteobacteria › Burkholderiales › Burkholderiaceae › Burkholderia › Burkholderia gladioli › Activity of Imipenem-Relebactam against...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Multirésistance aux médicaments › Multirésistance bactérienne aux médicaments › Activity of Imipenem-Relebactam against...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Carbapénèmes › Thiénamycine › Imipénem › Activity of Imipenem-Relebactam against...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Activity of Imipenem-Relebactam against...
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Amidohydrolases › bêta-Lactamases › Activity of Imipenem-Relebactam against...